跳至主要内容
临床试验/NCT01045837
NCT01045837已完成2 期

Effect of Addition of Short Course of Prednisolone to Gluten Free Diet and Gluten Free Diet Alone in the Recovery of Clinical, Histological and Immunological Features in Naive Adult Patients With Celiac Disease

All India Institute of Medical Sciences, New Delhi1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2009年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
33
试验地点
1
主要终点
Proportion of patients having improvement in symptoms at 4 weeks

研究概览

简要总结

Withdrawal of gluten, the culprit antigen, is the definite treatment for celiac disease. Weeks to months after gluten withdrawal from the diet before the clinical manifestations, histological features start improving. Many of the adult patients are in the critical phase where even weeks may matter especially those in their adolescence where height growth has limited potential.

Suppression of immune system using a short course of steroid might retard the immune mediated destruction of the villi while the effect of gluten withdrawal sets in. Steroids are known to be effective in the management of refractory celiac disease. Therefore, the investigators hypothesized that addition of a short course of steroid to gluten free diet may enhance intestinal mucosal recovery and thus clinical manifestations

详细描述

Celiac disease is a chronic systemic autoimmune disorder induced by gluten proteins present in wheat, barley, and rye. Steroids affect proliferative responses of both B and T cells in vitro, and the production of lymphokines (migratory inhibitory factor) by cultured cells. Steroids inhibit the effect of gluten proteins through their action on elements of the immune system. Glucocorticoids are reserved for severely ill patients, who present with celiac crisis, gliadin shock, and refractory sprue. We hypothesized that addition of a short course of steroid to gluten free diet may enhance intestinal mucosal recovery and thus clinical manifestations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Naïve patients with celiac disease (CD will be diagnosed as per revised European Society of Pediatric Gastroenterology and Nutrition criteria
  • Both sexes
  • Age>12 years

排除标准

  • Partially treated celiac disease
  • Co-existent systemic diseases
  • HIV seropositive
  • Seropositive with HBsAg , Anti HCV Ab
  • Past H/O tuberculosis
  • Evidence of active tuberculosis
  • Unwilling patient

研究组 & 干预措施

Prednisolone and Gluten free diet

Active Comparator

Gluten free diet and prednisolone in the dose of 1 mg/kg/d over a period of 4 weeks.

干预措施: Prednisolone and Gluten free diet (Drug)

Gluten free diet

Placebo Comparator

Gluten free alone will be given in this group

干预措施: Gluten free diet (Behavioral)

结局指标

主要结局

Proportion of patients having improvement in symptoms at 4 weeks

时间窗: 4 weeks

Proportion of patients having improvement in histological improvement by at least one grade at 4 weeks

时间窗: 4 weeks

次要结局

  • Proportion of patients showing normalization of histological abnormalities at 6 months(6 months)

研究者

发起方
All India Institute of Medical Sciences, New Delhi
申办方类型
Other
责任方
Principal Investigator
主要研究者

Govind K Makharia

Additional Professor

All India Institute of Medical Sciences, New Delhi

研究点 (1)

Loading locations...

相似试验